Lucid Diagnostics reports positive data from largest real-world experience of esophagal precancer detection with 12,000 patients.
A study analyzed data from around 12,000 patients who took Lucid's EsoGuard® Esophageal DNA Test with samples collected through its EsoCheck® Esophageal Cell Collection Device. The findings showcased the test's strong technical performance, quick cell-collection process, and appropriate utilization by physicians.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments